Your browser doesn't support javascript.
loading
Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017: data collection, management and analysis.
Bruyndonckx, Robin; Adriaenssens, Niels; Versporten, Ann; Hens, Niel; Monnet, Dominique L; Molenberghs, Geert; Goossens, Herman; Weist, Klaus; Coenen, Samuel.
Affiliation
  • Bruyndonckx R; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
  • Adriaenssens N; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
  • Versporten A; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
  • Hens N; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
  • Monnet DL; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
  • Molenberghs G; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
  • Goossens H; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
  • Weist K; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Coenen S; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
J Antimicrob Chemother ; 76(12 Suppl 2): ii2-ii6, 2021 07 26.
Article in En | MEDLINE | ID: mdl-34312651
ABSTRACT

OBJECTIVES:

This article introduces a series of articles on antibiotic consumption in the community between 1997 and 2017, which provide an update of previous articles covering the periods 1997-2003 and 1997-2009.

METHODS:

In this article, differences in participating countries, the ATC/DDD classification system, and data collection, validation and analysis between the current and previous series are described.

RESULTS:

In the previous series, 33 European countries provided valid data for further analysis, while the current series focused on 30 countries belonging to the EU or the European Economic Area (EEA). For both series, data were collected in accordance with the WHO ATC classification system. While the previous series reported data in accordance with the ATC/DDD index 2011, the current series employed the ATC/DDD index 2019. Both series focused on consumption of antibacterials for systemic use (ATC J01) and collected data expressed in DDD per 1000 inhabitants per day and packages per 1000 inhabitants per day. When studying consumption expressed in packages per 1000 inhabitants per day, countries reporting total care data, i.e. community and hospital sector combined, were included in the previous series but excluded in the current series. While the previous series used non-linear mixed models to evaluate time trends in antibiotic consumption, the current series allowed for inclusion of change-points with a data-driven location. In addition, both series assessed the composition and quality of antibiotic consumption in the EU/EEA.

CONCLUSIONS:

The updated analyses of two decades of ESAC-Net data provide the most comprehensive and detailed description of antibiotic consumption in the community in Europe.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Drug Utilization / Anti-Bacterial Agents Type of study: Health_economic_evaluation Limits: Humans Country/Region as subject: Europa Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Drug Utilization / Anti-Bacterial Agents Type of study: Health_economic_evaluation Limits: Humans Country/Region as subject: Europa Language: En Year: 2021 Type: Article